Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0001625257-17-000118
Filing Date
2017-12-15
Accepted
2017-12-15 12:43:44
Documents
1
Effectiveness Date
2017-12-15
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 11717
  Complete submission text file 0001625257-17-000118.txt   12872
Mailing Address 203 CRESCENT STREET SUITE 303 WALTHAM MA 02453
Business Address 203 CRESCENT STREET SUITE 303 WALTHAM MA 02453 781-902-8800
Fractyl Laboratories Inc. (Filer) CIK: 0001572616 (see all company filings)

EIN.: 273553477 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D/A | Act: 33 | File No.: 021-289968 | Film No.: 171258389
SIC: 3841 Surgical & Medical Instruments & Apparatus